These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8167604)

  • 21. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 24. Meningococcal disease in Ironville.
    Commun Dis Rep CDR Wkly; 1999 Aug; 9(34):297. PubMed ID: 10502876
    [No Abstract]   [Full Text] [Related]  

  • 25. [Meningococcal disease. new prevention strategies].
    Soult Rubio JA; Muñoz Sáez M; López Castilla JD
    An Esp Pediatr; 2001 Jan; 54(1):65-8. PubMed ID: 11181197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2006 Childhood and Adolescent Immunization Schedule: reflections at the 50th anniversary of the polio vaccine.
    Temte JL
    Am Fam Physician; 2006 Jan; 73(1):37, 40. PubMed ID: 16417063
    [No Abstract]   [Full Text] [Related]  

  • 27. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 28. Principles and practice of control of meningococcal disease in Norway.
    Lystad A
    NIPH Ann; 1980 Dec; 3(2):103-7. PubMed ID: 7219838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case definitions. Meningococcal disease.
    Epidemiol Bull; 2001 Dec; 22(4):14-5. PubMed ID: 12058681
    [No Abstract]   [Full Text] [Related]  

  • 30. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningococcal disease--New England, 1993-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(29):629-33. PubMed ID: 10458536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcus C vaccination programme.
    Murphy JF
    Ir Med J; 2000 Sep; 93(6):164. PubMed ID: 11105434
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiology and clinic of meningococcal infections. Indications for immunization].
    Goetz O; Peller P
    MMW Munch Med Wochenschr; 1980 Oct; 122(41):1411-2. PubMed ID: 6780820
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningococcal disease prophylaxis.
    J Iowa Med Soc; 1978 Dec; 68(12):457-8. PubMed ID: 722127
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 37. National guidelines for vaccine storage and transportation. The Childhood Immunization Division, Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Canada.
    Can Commun Dis Rep; 1995 Jun; 21(11):93-7. PubMed ID: 7647745
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the campaign on vaccination against meningococcal disease in Galicia. Methodology, advantages and disadvantages, Study of carriers].
    Malvar Pintos A
    Rev Esp Salud Publica; 1998; 72(5):393-400. PubMed ID: 9951330
    [No Abstract]   [Full Text] [Related]  

  • 39. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
    Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E
    Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.